Close Menu
    What's Hot

    UK Bulk Purchase Annuity Aggregate Premium Set To Fall but Number of Transactions Rises in H1

    22 July 2025

    Editor’s Letter – Volume 4, Issue 7, July 2025

    16 July 2025

    Significant Growth Potential in Equity Release/Reverse Mortgage Market but Change is Required to Get There

    16 July 2025
    Facebook X (Twitter) Instagram
    Instagram LinkedIn X (Twitter)
    Life Risk News
    • Home
    • Features

      Significant Growth Potential in Equity Release/Reverse Mortgage Market but Change is Required to Get There

      16 July 2025

      Insurance Capacity Boost and Growth in Small Deals Mark Busy First Half in UK Pension Risk Transfer Market

      16 July 2025

      Life Settlement Population Outlook Suggests Underwriting Frameworks Will Need to Continue to Adjust

      16 July 2025

      Q&A: Perry Koons, Director of Capital Markets, Maple Life Financial

      16 July 2025

      Nuanced Impact of CMI Model Change on Pension Risk Transfer Market

      16 July 2025
    • Commentary

      Mental Health Illness and Its Impact on Life Expectancy in the USA

      16 July 2025

      The Dangers of Defaulting to Fast Track

      16 July 2025

      Life Expectancy in Breast Cancer

      12 June 2025

      The Healthy Wealthy Population of the Life Settlement Market

      12 June 2025

      UK Life Insurers to Benefit from Robust Bulk Annuity Market in 2025

      14 May 2025
    • Events
    • Magazine
    • News

      UK Bulk Purchase Annuity Aggregate Premium Set To Fall but Number of Transactions Rises in H1

      22 July 2025

      Honda Group – UK Pension Scheme Completes Buy-In With Legal & General

      15 July 2025

      Utmost Life and Pensions Begins 2025 With Four Full Scheme Buy-Ins

      9 July 2025

      Chariot Re Launches, Announces Initial Reinsurance Transaction

      2 July 2025

      Molins UK Pension Fund Completes Bulk Purchase Annuity (BPA) Buy-In Transaction With Aviva

      1 July 2025
    Subscribe
    Life Risk News
    Home » Q&A: Chris Conway, Chief Development Officer, ISC Services

    Q&A: Chris Conway, Chief Development Officer, ISC Services

    Features 15 December 2023Greg WintertonBy Greg Winterton
    Twitter LinkedIn Email
    Share
    Twitter LinkedIn Email

    ISC Services Chief Development Officer, Chris Conway, has recently joined the Executive Board of industry group, the European Life Settlement Association (ELSA). Greg Winterton spoke to Conway to get his thoughts on the current state of the life settlement market and what his hopes are for 2024. 

    GW: Chris, let’s start with something of a retrospective. How would you describe how 2023 has been for the life settlement industry overall and why? 

    CC: My sense of the market is that it is continuing to grow, albeit slowly, due to the recent, significant rise in interest rates, which makes raising capital more challenging than has been the case in the past twenty years. Of course, the perennial issues associated with the lack of awareness among American consumers as to selling their unwanted or unneeded policies, the degree to which the efficiencies that should have been employed by the market in terms of technology that is available and legal but grossly underutilised, and the still pervasive efforts on the part of carriers to impede that growth in various ways, are challenges. Fortunately, the market not only continues to persist, but it appears to me to be re-tooling its appeal in the current economic environment to remain an attractive alternative to capital markets all over the world. 

    GW: When we spoke in July 2022, you said that you feel that the end investor doesn’t get into the weeds of the life expectancy underwriting part of the industry during their due diligence efforts as much as you think they should. Is that still the case? If so, is there anything that can be done about it? 

    CC: The number of firms approaching us to conduct formal due diligence hasn’t changed since our last conversation. I don’t know if that’s true for our competitors, but I suspect, for the most part, it is. It also seems as though there are more internal underwriting resources, meaning for most participants, an individual or two with some form of underwriting or medical background in more places. However, how these personnel are applied is difficult to discern, as is the degree to which they are specifically trained to conduct the underwriting employed by the commercial life expectancy firms. I do think more due diligence should be done directly with the commercial companies, including ours, but perhaps there are reasons I’ve yet to hear as to why the few exercises of this sort that are conducted occur after significant sums have already been invested. Having said all this, ours is a very difficult activity to get a firm handle on, and the adage ‘it’s an art and a science,’ still holds true.  

    GW: Back in September, you joined the Executive Board of ELSA. You have also served as the Chair of the Life Insurance Settlement Association (LISA) a few years ago. What knowledge from your time at LISA will you be bringing to ELSA? 

    CC: I hope I am able to contribute to ELSA by bringing my understanding of the different sectors of the marketplace LISA serves, such as the broker community, as well as some ability to liaise between the two groups. I also think there may be a growing need for an increasing degree of legislative and regulatory advocacy work to be conducted in the US and I hope I can assist ELSA’s members to understand and support such efforts for the benefit of the global marketplace. I also see ELSA as being a likely gateway for the entry of market participants from outside Europe, and to the degree I am able, I would like to serve as an additional emissary for these parties when they engage with LISA to help them understand the different nature and purpose of both associations and their complementary strengths that support the industry. 

    GW: Is there anything in particular that you are keen to be more involved in during the three years that you’ll be on the ELSA Executive Board? 

    CC: As you know, I am generally inclined to volunteer for nearly anything that has the potential to develop, support and further demonstrate the value and legitimacy of the marketplace. ELSA’s more broad view of ‘life risk’ is something I need to engage with more fully and I am eager to find ways to not only understand the larger space more broadly but also to try and engage similar parties operating in other markets, both in the US and abroad. I also hope to continue work with Life Risk News, which it has been a sincere pleasure to be a part of. 

    GW: Finishing up with something of an outlook question, Chris. Fast forward to this time next year. What needs to happen in 2024 for the life settlement industry to consider it a good year? 

    CC: I think if we can successfully make the case that the life risk asset class, and life settlements in particular, properly managed of course, offers attractive features and benefits regardless of the macro-economic environment du jour, and in so doing continue to attract capital from around the globe, we should consider it a win. Given how small an industry life settlements still is, and with the world as it is currently, from a variety of perspectives, I’d be happy to see us continue on our present path, and re-demonstrate the persistence of a good idea that’s still a bit too much of a secret. In short, every year we endure we grow, and I expect that trend to continue. 

    Chris Conway is Chief Development Officer at ISC Services 

    2023 - December Life Settlements Longevity Risk Q&A Secondary Life Markets Volume 2 Issue 12 - December 2023
    Share. Twitter LinkedIn Email

    Related Posts

    Significant Growth Potential in Equity Release/Reverse Mortgage Market but Change is Required to Get There

    16 July 2025

    Insurance Capacity Boost and Growth in Small Deals Mark Busy First Half in UK Pension Risk Transfer Market

    16 July 2025

    Life Settlement Population Outlook Suggests Underwriting Frameworks Will Need to Continue to Adjust

    16 July 2025

    Q&A: Perry Koons, Director of Capital Markets, Maple Life Financial

    16 July 2025

    Comments are closed.

    Most Popular

    Significant Growth Potential in Equity Release/Reverse Mortgage Market but Change is Required to Get There

    16 July 2025

    Insurance Capacity Boost and Growth in Small Deals Mark Busy First Half in UK Pension Risk Transfer Market

    16 July 2025

    Life Settlement Population Outlook Suggests Underwriting Frameworks Will Need to Continue to Adjust

    16 July 2025

    Mental Health Illness and Its Impact on Life Expectancy in the USA

    16 July 2025
    Ad

    Your trusted source for capital markets participation in Life Risk

    X (Twitter) Instagram LinkedIn
    Life Risk
    • About Life Risk News
    • Get In Touch
    • Our Team
    • Copyright Notice
    • Terms and Conditions
    • Privacy Policy
    • Sitemap
    Coverage
    • Home
    • Features
    • Events
    • Commentary
    Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the ...
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT